Search results
Results from the WOW.Com Content Network
Giant-cell tumor of the bone (GCTOB), is a relatively uncommon bone tumor. It is characterized by the presence of multinucleated giant cells ( osteoclast -like cells). Malignancy in giant-cell tumor is uncommon and occurs in about 2% of all cases.
An aneurysmal bone cyst can arise from a pre-existing chondroblastoma, a chondromyxoid fibroma, an osteoblastoma, a giant cell tumor, or fibrous dysplasia. A giant cell tumor is the most common cause, occurring in 19–39% of cases. Less frequently, it results from some malignant tumors, such as osteosarcoma, chondrosarcoma, and ...
X-ray of a giant cell bone tumor in the head of the 4th metacarpal of the left hand. An arm bone tumor. Bone tumors are traditionally classified as noncancerous (benign) or cancerous (malignant). [1] Several features of bone tumors and soft tissue tumors overlap. [7] Their classification was revised by the World Health Organization (WHO) in ...
Tenosynovial giant cell tumor (TGCT) is a non-malignant tumor defined histologically as inclusions of “osteoclast-like” multinucleated giant cells, hemosiderin, and macrophages. [1] This histology can present one of 2 clinically distinct ways. TGCT tumors often develop from the lining of joints (also known as synovial tissue).
A giant cell (also known as a multinucleated giant cell, or multinucleate giant cell) is a mass formed by the union of several distinct cells (usually histiocytes), often forming a granuloma. [ 1 ] Although there is typically a focus on the pathological aspects of multinucleate giant cells (MGCs), they also play many important physiological roles.
Language links are at the top of the page across from the title.
Histologically, it is impossible to distinguish a Brown tumor of hyperparathyroidism from other giant cell lesions of bone. Rarely a focal collection of osteoclasts (brown tumor) may occur in relation to periosteum and be indistinguishable from a peripheral giant cell granuloma (giant cell epulis).
Denosumab, sold under the brand name Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. [21] [22] The most common side effects are joint and muscle pain in the arms or legs. [23]